ALS is worse by nearly every measure. It kills most people within two to three years of diagnosis, strips away the ability to move, speak, eat, and breathe, and has no treatment that can stop it. Parkinson’s disease is serious and life-altering, but it progresses over decades, responds to medication, and allows most people to live well into old age. The two conditions affect the nervous system in fundamentally different ways, and that difference shapes everything from daily life to long-term outlook.
How Survival Compares
The starkest difference is how long people live after diagnosis. In a CDC-supported study of 456 ALS cases, the median survival from diagnosis was just 21 months. Fewer than half of patients survived longer than two years. Some people live five or ten years with ALS, but they are the exception.
Parkinson’s, by contrast, shortens life expectancy modestly. A person diagnosed at age 65 loses roughly seven years of life expectancy compared to someone without the disease. But that still means living into the mid-to-late seventies or beyond. For people diagnosed after 85, the gap in life expectancy nearly disappears. Parkinson’s is a disease you live with for a long time. ALS is a disease that takes over quickly.
What Each Disease Does to the Body
Both diseases attack the nervous system, but they target different parts of it and cause very different problems.
ALS destroys the motor neurons that connect the brain to the muscles. As those neurons die, muscles weaken, waste away, and eventually stop working entirely. This happens in a relentless sequence: you might first notice weakness in a hand or foot, then lose the ability to walk, then lose the ability to use your arms, then struggle to speak and swallow. The final stage is respiratory failure. The muscles that control breathing, including the diaphragm, stop functioning. Respiratory failure is the leading cause of death in ALS, and for most patients it arrives within a few years of the first symptoms.
Parkinson’s works differently. It destroys cells in the brain that produce dopamine, a chemical messenger involved in coordinating movement. The result is tremor, stiffness, slowness, and balance problems that worsen gradually over years. In the early stages, symptoms are often mild and manageable. Many people with Parkinson’s continue working, exercising, and living independently for a decade or more after diagnosis. The disease does progress into more disabling stages, but the timeline is measured in decades, not months.
Treatment Options
This is where the gap between the two diseases becomes even clearer. Parkinson’s has effective symptom management. Dopamine-replacement medications can dramatically improve movement, reduce tremor, and restore quality of life for years. Physical therapy, exercise, and in some cases surgical interventions can further help. None of these treatments cure Parkinson’s or stop it from progressing, but they make a meaningful difference in how people feel and function day to day.
ALS has almost nothing comparable. The main approved medication reduces mortality by about 35%, but in practical terms that translates to a few additional months of life, not years. No drug reverses the muscle loss or restores function. Treatment for ALS is largely supportive: breathing devices, feeding tubes, communication aids, and physical therapy to maintain comfort. The disease continues advancing regardless of intervention.
Cognitive and Emotional Effects
Both diseases can affect thinking and mood, though in different ways. About 50% of people with ALS show some degree of cognitive changes similar to a type of dementia that affects personality, decision-making, and language. Roughly 15 to 18% of ALS patients develop full dementia of this kind. This means that for some people with ALS, the disease attacks both body and mind simultaneously.
Parkinson’s also carries a risk of dementia, particularly in later stages. Depression and anxiety are common throughout the disease. But because Parkinson’s progresses slowly, cognitive decline typically doesn’t become severe until many years after diagnosis, giving people a long window of preserved mental function.
How People Die From Each Disease
In ALS, death is almost always caused by respiratory failure. The muscles responsible for breathing weaken to the point where the body can no longer take in enough oxygen or expel enough carbon dioxide. This can happen gradually or, in some cases, relatively suddenly. A ventilator can extend life, but most ALS patients eventually choose not to pursue long-term mechanical ventilation.
In advanced Parkinson’s, the most common serious complication is aspiration pneumonia, which occurs when swallowing difficulties cause food or saliva to enter the lungs. Postmortem studies have found that aspiration pneumonia is the primary cause of death in about 30% of Parkinson’s patients. Once a person with Parkinson’s develops aspiration pneumonia, the mortality rate is steep: roughly 24% within one month, rising to 65% within a year. But this complication typically occurs very late in the disease, after many years of living with the condition.
Quality of Life Over Time
Perhaps the most important difference for someone trying to understand these two diseases is what daily life looks like. A person diagnosed with Parkinson’s at 60 might spend the next ten years with manageable symptoms, staying active and independent with the help of medication. The later years bring increasing difficulty, but there is time to adapt, plan, and live.
A person diagnosed with ALS faces a different reality. Within months, activities that were effortless become impossible. Many people go from full independence to needing help with every basic task within one to two years. The mind often remains sharp while the body shuts down, which many patients and families describe as one of the cruelest aspects of the disease. There is little time, and there is no plateau where things stabilize.
Both diseases are devastating. But ALS is faster, less treatable, and more uniformly fatal. Parkinson’s is a long, difficult road. ALS is a short one with no turns.